Preparation of nanocrystals with mixtures of organic ligands

US10224398B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10224398-B2
Application numberUS-201113976621-A
CountryUS
Kind codeB2
Filing dateDec 23, 2011
Priority dateDec 28, 2010
Publication dateMar 5, 2019
Grant dateMar 5, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Semiconductor nanocrystals prepared using a mixture of organic ligands (e.g., oxoacids), as well as compositions, kits, and methods of using such semiconductor nanocrystals are disclosed.

First claim

Opening claim text (preview).

What is claimed is: 1. A population of semiconductor nanocrystals, wherein each nanocrystal in the population comprises: a) an elongated semiconductor core comprising CdSe or CdSeTe; and b) a semiconductor shell layer disposed on the semiconductor core, and at least two different oxoacid compounds, wherein the at least two different oxoacid compounds comprise ethylphosphonic acid and tetradecylphosphonic acid, wherein the mole fraction of ethylphosphonic acid relative to the total number of moles of oxoacid compounds is greater than about 0.5%, wherein the population of semiconductor nanocrystals exhibits a quantum yield of greater than 70%, wherein the semiconductor core of each nanocrystal has a first aspect ratio and the nanocrystal has a second aspect ratio, wherein the second aspect ratio is less than the first aspect ratio. 2. The population of claim 1 , wherein each nanocrystal in the population further comprises a hydrophilic overcoating on the semiconductor shell layer that renders the nanocrystal dispersible in an aqueous medium. 3. The population of claim 1 , wherein each nanocrystal in the population is associated with a biological molecule, cell, or drug. 4. The population of claim 1 , wherein the shell layer comprises a semiconductor material selected from the group consisting of a Group II-VI, Group II-VI-VI, Group III-V, Group III-III-V, Group III-V-V and Group II-II-VI semiconductor material. 5. The population of claim 1 , wherein the mole fraction of the ethylphosphonic acid relative to the total number of moles of oxoacid compounds is greater than about 2%. 6. The population of claim 1 , wherein the mole fraction of the ethylphosphonic acid relative to the total number of moles of oxoacid compounds is greater than about 5%. 7. The population of claim 1 , wherein the mole fraction of the ethylphosphonic acid relative to the total number of moles of oxoacid compounds is about 0.5% to about 20%. 8. The population of claim 1 , wherein the mole fraction of the ethylphosphonic acid relative to the total number of moles of oxoacid compounds is about 2% to about 20%. 9. The population of claim 1 , wherein the mole fraction of the ethylphosphonic acid relative to the total number of moles of oxoacid compounds is about 5% to about 15%. 10. A dispersion of semiconductor nanocrystals, comprising: a population of semiconductor nanocrystals according to claim 1 ; and an aqueous or organic medium. 11. A kit for labeling cells, comprising a) a population of semiconductor nanocrystals according to claim 1 ; and b) instructions for labeling cells with the population of nanocrystals. 12. A method of detecting a target species in a sample, comprising: contacting a sample suspected of containing a target species with the population of claim 1 for a time sufficient to bind the target species to at least one nanocrystal in the population; and monitoring fluorescence emission to detect the presence of the at least one nanocrystal, thereby detecting the target species in the sample. 13. A population of semiconductor nanocrystals, wherein each nanocrystal in the population comprises: a) an elongated semiconductor core; and b) a semiconductor shell layer disposed on the semiconductor core, and at least two different oxoacid compounds, wherein the at least two different oxoacid compounds comprise ethylphosphonic acid and tetradecylphosphonic acid, wherein the semiconductor core of each nanocrystal has a first aspect ratio and the nanocrystal has a second aspect ratio, wherein the second aspect ratio is less than the first aspect ratio. 14. The population of semiconductor nanocrystals of claim 13 , wherein the elongated semiconductor core comprises CdSe or CdSeTe. 15. The population of semiconductor nanocrystals of claim 13 , wherein the population of semiconductor nanocrystals exhibits a quantum yield of greater than 70%. 16. A population of semiconductor nanocrystals, wherein each nanocrystal in the population comprises: a) an elongated semiconductor core comprising CdSe or CdSeTe; and b) a semiconductor shell layer disposed on the semiconductor core, and at least two different oxoacid compounds, wherein the at least two different oxoacid compounds comprise a first oxoacid compound with a lower molecular weight and a second oxoacid compound with a higher molecular weight, wherein the mole fraction of the lower molecular weight oxoacid compound relative to the total number of moles of oxoacid compounds is greater than about 0.5%, wherein the first oxoacid compound is selected from C 1 -C 10 alkylphosphonic acid compounds and the second oxoacid compound is selected from C 10 -C 20 alkylphosphonic acid compounds, wherein the population of semiconductor nanocrystals exhibits a quantum yield of greater than 70%, wherein the semiconductor core of each nanocrystal has a first aspect ratio and the nanocrystal has a second aspect ratio, wherein the second aspect ratio is less than the first aspect ratio. 17. The population of claim 16 , wherein at least one of the oxoacid compounds is methylphosphonic acid, butylphosphonic acid, hexylphosphonic acid or octylphosphonic acid.

Assignees

Inventors

Classifications

  • using solutions · CPC title

  • AIIIBV compounds {wherein A is B, Al, Ga, In or Tl and B is N, P, As, Sb or Bi} · CPC title

  • characterised by shape · CPC title

  • Nanooptics, e.g. quantum optics or photonic crystals · CPC title

  • Manufacture or treatment of nanostructures · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10224398B2 cover?
Semiconductor nanocrystals prepared using a mixture of organic ligands (e.g., oxoacids), as well as compositions, kits, and methods of using such semiconductor nanocrystals are disclosed.
Who is the assignee on this patent?
Bartel Joseph, Chen Yongfen, Lermer Noah, and 5 more
What technology area does this patent fall under?
Primary CPC classification B82Y30/00. Mapped technology areas include Operations & Transport.
When was this patent published?
Publication date Tue Mar 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).